SEC Form 4 · accession 0001127602-18-014005
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & CEO · Director
Period of report
Apr 2, 2018
Accepted (ET)
Apr 4, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 2, 2018 | M | 547 | $52.65 | A | 687 | D | |
| Common StockF2 | Apr 2, 2018 | S | 204 | $110.0923 | D | 483 | D | |
| Common StockF3 | Apr 2, 2018 | S | 343 | $111.2799 | D | 140 | D | |
| Common Stock | Apr 3, 2018 | M | 21,512 | $52.65 | A | 21,652 | D | |
| Common StockF4 | Apr 3, 2018 | S | 1,506 | $111.8696 | D | 20,146 | D | |
| Common StockF5 | Apr 3, 2018 | S | 2,600 | $113.0244 | D | 17,546 | D | |
| Common StockF6 | Apr 3, 2018 | S | 6,900 | $114.0953 | D | 10,646 | D | |
| Common StockF7 | Apr 3, 2018 | S | 5,279 | $115.1816 | D | 5,367 | D | |
| Common StockF8 | Apr 3, 2018 | S | 5,127 | $115.9532 | D | 240 | D | |
| Common Stock | Apr 3, 2018 | S | 100 | $117.80 | D | 140 | D | |
| Common Stock | holding | — | — | — | 683,489 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $52.65 | Apr 2, 2018 | M | 547 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 547 | 255,699 | D |
| Stock Options | $52.65 | Apr 3, 2018 | M | 21,512 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 21,512 | 234,187 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2This transaction was executed in multiple trades at prices ranging from $110.00 to $110.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $111.08 to $111.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $111.48 to $112.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $112.50 to $113.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $113.57 to $114.545. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $114.61 to $115.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $115.62 to $116.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.